Late-Breaking Clinical Trials

Late-Breaking Clinical Trials provides attendees with the latest in clinical research, techniques, and technologies. Accepted late-breaking clinical trials will be featured at Heart Rhythm 2018 and published in the July issue of the HeartRhythm Journal, the leading publication for heart rhythm disorders. Attend these sessions to hear the latest science and stay ahead in the field.


B-LBCT01. Late-Breaking Clinical Trials

Thursday, May 10
8 – 9:30 a.m.

  • B-LBCT01-01 - Prevention of Arrhythmia Device Infection Trial (padit)
  • B-LBCT01-02 - Randomized Controlled Trial of Cardiac Contractility Modulation in Heart Failure: The FIX-HF-5C Study
  • B-LBCT01-03 - Targeted Left Ventricular Lead Implantation in Non-Left Bundle Branch Block Patients: Primary Results of The Enhance CRT Pilot Study
  • B-LBCT01-04 - A Randomized Pragmatic Trial of Strategies of Permanent Pacemaker Versus Implantable Cardiac Monitor in Older Patients with Syncope and Bifascicular Block
  • B-LBCT01-05 - Catheter Ablation vs. Antiarrhythmic Drug Therapy for Atrial Fibrillation: The Results of The Cabana Multicenter International Randomized Clinical Trial

B-LBCT02. Late-Breaking Updates From Clinical Trials and Registries 

Friday, May 11

8 – 9:30 a.m.

  • B-LBCT02-01 - Three-year Outcomes After Botulinum Toxin Injections into Epicardial Fat Pads for Atrial Fibrillation Prevention in Patients Undergoing Coronary Artery Bypass Grafting
  • B-LBCT02-02 - Myocarditis Is an Underrecognized Etiology of Symptomatic Premature Ventricular Contractions - Insights from The Myocarditis and Ventricular Arrhythmia (MAVERIC) Registry
  • B-LBCT02-03 - Lower Adherence Direct Oral Anticoagulants Use Is Associated with Increased Risk of Thromboembolic Events Than Warfarin - Understanding the Real-world Performance of Systemic Anticoagulation in Atrial Fibrillation
  • B-LBCT02-04 - Atrial Fibrillation Burden and Impact on Mortality and Hospitalization - The CASTLE-AF Trial
  • B-LBCT02-05 - Device-related Thrombus After Left Atrial Appendage Closure with Watchman: Incidence, Predictors, and Outcomes

B-LBCT03. Late-Breaking Innovations

Friday, May 11
4:30 – 6 p.m.

  • LBCT03-01 - Intramural Needle Ablation for Refractory Ventricular Arrhythmias: Safety and Outcomes
  • LBCT03-02 - First In-human Data on Multi-Electrode Contact Mapping Plus Ablation for Treatment of Atrial Fibrillation
  • LBCT03-03 - Feasibility of Extravascular Pacing, Sensing and Defibrillation from a Novel Substernal lead: The Acute Extravascular Defibrillation, Pacing and Electrogram (ASD2) Study
  • LBCT03-04 - Av Synchronous Pacing with a Ventricular Leadless Pacemaker: Primary Results from the Marvel Study
  • LBCT03-05 - First Clinical Report of Atrial Fibrillation Ablation with Pulsed Electric Fields: An Ultra-Rapid, Tissue-Selective Modality for Cardiac Ablation
  • LBCT03-06 - A Prospective, Blinded Evaluation of a Novel Filter Designed to Reduce Inappropriate Shocks by the Subcutaneous Implantable Defibrillator


Exit Heart Rhythm Scientific Sessions

You are about to exit the Heart Rhythm Scientific Sessions website. Upon clicking the Continue button, you will be redirected to an external website.